IL1B and infection: A third line of evidence supporting the notion that nontranslocated NADase modulates inflammasome-dependent IL-1β levels was generated by adding increasing amounts of pure active recombinant NADase (rNADase) into BMDM infections with nga(G330D) bacteria, resulting in a dose-dependent decrease of the IL-1β levels (Fig. 3C).